WeightWatchers moves into obesity drug market with Sequence purchase
WeightWatchers announced plans to buy telehealth platform Weekend Health, also known as Sequence, in a move toward offering prescription weight loss drugs. The company said the cash and equity transaction is valued at $132 million, but the effective net purchase price is $106 million. The deal is set to close in the second quarter this […]